Pharmaceutical Product Development LLC-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Pharmaceutical Product Development LLC - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8014210
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月22日
◆ページ数:56
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Pharmaceutical Product Development LLC (PPD) is a contract research organization (CRO), which offers drug discovery, development and lifecycle management services. The company’s service portfolio encompasses early development clinical trial services, drug research and development, regulatory support and late-stage clinical trial management, among others. It has expertise in clinical trials in therapy areas including cardiovascular system, central nervous system, dermatology, gastroenterology, hematology, cancer, infectious diseases, ophthalmology, respiratory and endocrine systems, metabolism, rare diseases and urology. PPD’s clients include pharmaceutical, biotechnology, medical device, and academic and government organizations. The company has a presence in North America, South America, Europe, Middle East, Africa, and Asia-Pacific. PPD is headquartered in Wilmington, North Carolina, the US.

Pharmaceutical Product Development LLC – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Pharmaceutical Product Development LLC, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6
Pharmaceutical Product Development LLC, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 7
Pharmaceutical Product Development LLC, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8
Pharmaceutical Product Development LLC, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 9
Pharmaceutical Product Development LLC, Medical Devices Deals, 2011 to YTD 2017 10
Pharmaceutical Product Development LLC, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 11
Pharmaceutical Product Development LLC, Pharmaceuticals & Healthcare, Deal Details 13
Asset Purchase 13
Pharmaceutical Product Development Acquires Sequential Parallel Comparison Design from RCT Logic 13
Venture Financing 14
Oncofactor Secures US$2.1 Million In Series A Financing 14
Private Equity 15
Carlyle Group And Hellman & Friedman Complete Acquisition Of PPD For US$3.9 Billion 15
Partnerships 18
Pharma Product Development Enters Into Licensing Agreement With Tessella For FACTS, Adaptive Trial Design Software 18
Treos Bio Enters into Agreement with Pharmaceutical Product Development 19
Pharmaceutical Product Development Enters into Agreement with Frenova Renal Research 20
Moderna Therapeutics Enters into Agreement with Pharmaceutical Product Development 21
Pharma Product Development Enters into Agreement with BARDA 22
Pharma Product Development Enters into Contract Agreement with USAMMDA and USAMRMC 23
Pharmaceutical Product Development Forms Joint Venture with Shin Nippon Biomedical 24
Pharmaceutical Product Development Forms Joint Venture with Shin Nippon Biomedical 25
BioAtla Enters into Co-Development Agreement with BioDuro 26
Pharmaceutical Product Development and X-Chem Form Joint Venture 27
Pharma Product Development Expands Co-Development Agreement With VirtualScopics 28
Elan Enters Into Collaboration With Pharma Product Development 29
Pharma Product Development Forms Joint Venture With Taijitu Biologics 30
Debt Offering 31
Jaguar Holding Company II and Pharmaceutical Product Development to Raise USD1,125 Million in Private Placement of Notes 31
Pharmaceutical Product Development Announces Public Offering Of Notes For US$500 Million 32
Acquisition 33
LabCorp May Acquire Pharmaceutical Product Development 33
BioDuro Acquires Formex 34
Pharmaceutical Product Development Exercises Option to Acquire Remaining 36% Stake in X-Chem 35
Pharmaceutical Product Development Acquires Acurian, Patient Recruitment Company 36
Pharma Product Development Acquires 64% Stake In X-Chem For US$15.5 Million 37
Pharmaceutical Product Development LLC – Key Competitors 38
Pharmaceutical Product Development LLC – Key Employees 39
Pharmaceutical Product Development LLC – Locations And Subsidiaries 40
Head Office 40
Other Locations & Subsidiaries 40
Joint Venture 43
Recent Developments 44
Strategy And Business Planning 44
May 18, 2017: PPD Expands Vaccine Development Laboratory 44
Feb 28, 2017: PPD Introduces Rare Disease and Pediatric Center of Excellence 45
Jan 30, 2017: PPD to Open New Clinical Research Unit in Las Vegas 46
Dec 14, 2016: PPD Expands Stability Storage and Sample Distribution at Wisconsin GMP Lab 47
Oct 20, 2016: PPD Expands GMP Lab Services in Athlone, Ireland 48
Jan 06, 2016: X-Chem Established as Independent, Privately Owned Biotechnology Company 49
Government and Public Interest 50
Mar 02, 2017: PPD Awarded National Institutes of Health Contract for HIV Research Support 50
Product News 51
Feb 10, 2016: PPD Enhances Central Lab Data Capabilities via Preclarus 51
Other Significant Developments 52
Oct 24, 2017: Evidera Expands Patient-Centered Research Services 52
May 08, 2017: PPD Creates Dedicated Real-world Research and Market Access Unit by Combining Medical Affairs Research Operations and Evidera 53
Mar 23, 2017: PPD Announces Industry-First Apprenticeship for Clinical Research Associates 54
Apr 26, 2016: PPD Expands Medical Communications Operations into Asia-Pacific Region 55
Appendix 56
Methodology 56
About GlobalData 56
Contact Us 56
Disclaimer 56

List of Tables
Pharmaceutical Product Development LLC, Pharmaceuticals & Healthcare, Key Facts 2
Pharmaceutical Product Development LLC, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6
Pharmaceutical Product Development LLC, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 7
Pharmaceutical Product Development LLC, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8
Pharmaceutical Product Development LLC, Deals By Therapy Area, 2011 to YTD 2017 9
Pharmaceutical Product Development LLC, Medical Devices Deals, 2011 to YTD 2017 10
Pharmaceutical Product Development LLC, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 11
Pharmaceutical Product Development Acquires Sequential Parallel Comparison Design from RCT Logic 13
Oncofactor Secures US$2.1 Million In Series A Financing 14
Carlyle Group And Hellman & Friedman Complete Acquisition Of PPD For US$3.9 Billion 15
Pharma Product Development Enters Into Licensing Agreement With Tessella For FACTS, Adaptive Trial Design Software 18
Treos Bio Enters into Agreement with Pharmaceutical Product Development 19
Pharmaceutical Product Development Enters into Agreement with Frenova Renal Research 20
Moderna Therapeutics Enters into Agreement with Pharmaceutical Product Development 21
Pharma Product Development Enters into Agreement with BARDA 22
Pharma Product Development Enters into Contract Agreement with USAMMDA and USAMRMC 23
Pharmaceutical Product Development Forms Joint Venture with Shin Nippon Biomedical 24
Pharmaceutical Product Development Forms Joint Venture with Shin Nippon Biomedical 25
BioAtla Enters into Co-Development Agreement with BioDuro 26
Pharmaceutical Product Development and X-Chem Form Joint Venture 27
Pharma Product Development Expands Co-Development Agreement With VirtualScopics 28
Elan Enters Into Collaboration With Pharma Product Development 29
Pharma Product Development Forms Joint Venture With Taijitu Biologics 30
Jaguar Holding Company II and Pharmaceutical Product Development to Raise USD1,125 Million in Private Placement of Notes 31
Pharmaceutical Product Development Announces Public Offering Of Notes For US$500 Million 32
LabCorp May Acquire Pharmaceutical Product Development 33
BioDuro Acquires Formex 34
Pharmaceutical Product Development Exercises Option to Acquire Remaining 36% Stake in X-Chem 35
Pharmaceutical Product Development Acquires Acurian, Patient Recruitment Company 36
Pharma Product Development Acquires 64% Stake In X-Chem For US$15.5 Million 37
Pharmaceutical Product Development LLC, Key Competitors 38
Pharmaceutical Product Development LLC, Key Employees 39
Pharmaceutical Product Development LLC, Other Locations 40
Pharmaceutical Product Development LLC, Subsidiaries 42
Pharmaceutical Product Development LLC, Joint Venture 43

★海外企業調査レポート[Pharmaceutical Product Development LLC-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • TransAtlantic Petroleum Ltd (TAT):企業の財務・戦略的SWOT分析
    TransAtlantic Petroleum Ltd (TAT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Actuant Corporation:企業のM&A・事業提携・投資動向
    Actuant Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Actuant Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), …
  • Crossject SA (ALCJ)-医療機器分野:企業M&A・提携分析
    Summary Crossject SA (Crossject) is a medical device company that develops injection systems. The company offers products which include methotrexate, epinephrin, sumatriptan, L15, naloxone, apomorphine, and midazolam. It uses its needle-free injection system to develop a pipeline of supergenerics by …
  • Arise AB (ARISE):電力:M&Aディール及び事業提携情報
    Summary Arise AB (Arise) is an integrated onshore wind company. It involves in project development and sale of electricity generation through its onshore wind turbines. The company manages exploration, construction, sale, long-term management and financing of its own and third party wind farms. Aris …
  • VTB Bank:戦略・SWOT・企業財務分析
    VTB Bank - Strategy, SWOT and Corporate Finance Report Summary VTB Bank - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, …
  • AutoZone, Inc.:企業の戦略・SWOT・財務分析
    AutoZone, Inc. - Strategy, SWOT and Corporate Finance Report Summary AutoZone, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • KINeSYS Inc.:企業の戦略・SWOT・財務分析
    KINeSYS Inc. - Strategy, SWOT and Corporate Finance Report Summary KINeSYS Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • LA DORIA S.p.A.:企業の戦略・SWOT・財務情報
    LA DORIA S.p.A. - Strategy, SWOT and Corporate Finance Report Summary LA DORIA S.p.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Tecpetrol SA:石油・ガス:M&Aディール及び事業提携情報
    Summary Tecpetrol SA (Tecpetrol), a subsidiary of Techint Group, is an oil and gas exploration and production company. The company acquires, explores, produces, transports and distributes oil and gas. It operates fields and blocks in Argentina, Venezuela, Bolivia, Ecuador, Mexico, Peru and Colombia. …
  • Yasuhara Chemical Co Ltd (4957):企業の財務・戦略的SWOT分析
    Yasuhara Chemical Co Ltd (4957) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Honeywell International Inc (HON):電力:M&Aディール及び事業提携情報
    Summary Honeywell International Inc. (Honeywell) is a diversified manufacturing and technology company. The company offers avionics, aircraft engines, systems and service solutions; environmental and combustion controls, sensing controls, security and life safety products and services, scanning and …
  • Iberdrola, S.A.:企業の戦略・SWOT・財務情報
    Iberdrola, S.A. - Strategy, SWOT and Corporate Finance Report Summary Iberdrola, S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Drax Group Plc:発電所・企業SWOT分析
    Drax Group Plc – Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees (exe …
  • Cellnet Group Ltd (CLT):企業の財務・戦略的SWOT分析
    Cellnet Group Ltd (CLT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Nuvia Ltd:企業の戦略的SWOT分析
    Nuvia Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. Th …
  • GE Healthcare LLC-製薬・医療分野:企業M&A・提携分析
    Summary GE Healthcare LLC (GE Healthcare) a business unit of General Electric Company, is a global medical device provider that designs, develops, manufactures, and distributes diagnostic imaging and clinical systems; products and services for drug discovery, biopharmaceutical manufacturing and cell …
  • Genuine Parts Company (GPC):企業の財務・戦略的SWOT分析
    Genuine Parts Company (GPC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • SalvaRx Group plc (SALV):企業の財務・戦略的SWOT分析
    Summary SalvaRx Group Plc (SalvaRx), formerly 3Legs Resources plc, is a drug development company that offers acquiring and operating drug development programmes in immuno-oncology. The company offers immune oncology. It invests in novel cancer immune-therapies. SalvaRx provides development of a pipe …
  • Imperial Dax Company, Inc:企業の戦略・SWOT・財務情報
    Imperial Dax Company, Inc - Strategy, SWOT and Corporate Finance Report Summary Imperial Dax Company, Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Terna Energy SA (TENERGY):企業の財務・戦略的SWOT分析
    Terna Energy SA (TENERGY) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆